These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16050004)
1. Medical innovation and patent gridlock. James JS AIDS Treat News; 2005 May; (412):6-8. PubMed ID: 16050004 [TBL] [Abstract][Full Text] [Related]
2. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices. Pinzone JD J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775 [No Abstract] [Full Text] [Related]
3. [From the molecule to the drug: innovation or distribution]. Ménard HA Union Med Can; 1993; 122(1):4. PubMed ID: 8465475 [No Abstract] [Full Text] [Related]
4. [The patent is "engine" in drug development]. Bergström R Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246 [No Abstract] [Full Text] [Related]
5. How should we support pharmaceutical innovation? Grootendorst P Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991 [TBL] [Abstract][Full Text] [Related]
6. A new prize system for drug innovation. Gandjour A; Chernyak N Health Policy; 2011 Oct; 102(2-3):170-7. PubMed ID: 21724290 [TBL] [Abstract][Full Text] [Related]
7. The Health Impact Fund: boosting pharmaceutical innovation without obstructing free access. Pogge T Camb Q Healthc Ethics; 2009; 18(1):78-86. PubMed ID: 19091149 [No Abstract] [Full Text] [Related]
8. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
9. World CAB meets with Gilead. Huff B GMHC Treat Issues; 2006; 20(4-7):6-8. PubMed ID: 17228449 [No Abstract] [Full Text] [Related]
10. Medical pharmaceuticals and distributive justice. Boylan M Camb Q Healthc Ethics; 2008; 17(1):30-44. PubMed ID: 18462543 [No Abstract] [Full Text] [Related]
11. [Patients, patents and profits]. Haug C Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2921. PubMed ID: 18026234 [No Abstract] [Full Text] [Related]
12. [Drug industry's misuse of patents must be prevented]. Magnusson PA Lakartidningen; 2008 Feb 20-26; 105(8):555. PubMed ID: 18363299 [No Abstract] [Full Text] [Related]
13. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
15. The London Agreement and the future of parallel imports. Muir J Nat Biotechnol; 2008 Aug; 26(8):877-9. PubMed ID: 18688237 [No Abstract] [Full Text] [Related]
16. A new approach to drug development. Brown S N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948 [No Abstract] [Full Text] [Related]
17. [Patients, patents and profits]. Roland PC Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741 [No Abstract] [Full Text] [Related]
19. [Discount for only one drug of the same group leads to impaired health care quality]. Bergström R Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044 [No Abstract] [Full Text] [Related]